AUSTRALIAN vitamins group
Swisse Wellness has declared
a $49m profit for its first three
months under the ownership of
Biostime International, propelling
the brand to pole position in
healthcare on the two large
Chinese online sites of Tmall and
Taobao according to Fairfax media.
The results are now being made
public for the first time as a result
of being part of Hong Kong stock
exchange listed company Biostime.
For the three months to end
Dec 2015 Swisse contributed
revenue of 838.1 million yuan or
approximately AU$169m.
If that result was extrapolated
to a full year’s business it would
challenge the result of ASX-listed
Blackmores, stated for the six
months ended Dec 2015 as $342m,
up 66% with net profit tripled to
$48.3m (PD 25 Feb).The above article was sent to subscribers in Pharmacy Daily's issue from 01 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Apr 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.